| ۲۱ | Curcumin affects adipose tissue-derived mesenchymal stem cell aging through TERT gene expression | Pirmoradi S- Fathi E- Farahzadi R- Pilehvar-Soltanahmadi Y- Zarghami N | Drug Research | Apr-2018 |
| ۲۲ | Acute erythroid leukemia with multilineage dysplasia in a cat | Shirani D- Nassiri SM- Aldavood SJ- Seddigh HS- Fathi E | The Canadian Veterinary Journal. | Apr-2011 |
| ۲۳ | Survey on impact of trace elements (Cu, Se AND Zn) on veterinary and human mesenchymal stem cells | Fathi E- Farhzadi R | Rom J Biochem | 2105 |
| ۲۴ | L-carnitine reduced cellular aging of bone marrow resident C-kit+ hematopoietic stem cells through telomere dependent pathways. | Fathi E- Montazersaheb S- Sanaat Z- Nakhlband A- Vandghanooni S- Farahzadi R- Vietor I | Current Stem Cell Research & Therapy | 2022/05/11 |
| ۲۵ | Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect | Montazersaheb S- Ehsani A- Fathi E- Farahzadi R | Oxidative Medicine and Cellular Longevity | 2022/04/01 |
| ۲۶ | The Potential of Graphene Oxide and Reduced Graphene Oxide in Diagnosis and Treatment of Cancer | Keramat A- Kadkhoda J- Farahzadi R- Fathi E*- Davaran S | Current Medicinal Chemistry | 2022 |
| ۲۷ | An Overview of Autophagy in Hematopoietic Stem Cell Transplantation | Montazersaheb S- Ehsani A- Fathi E- Farahzadi R- Vietor I | Frontiers in Bioengineering and Biotechnology | 2022 |
| ۲۸ | Adipose TissueMesenchymal Stem Cells Caused to Change the Methylation Status of hTERT GenePromoter CpG Islands of Molt-4 Leukemia Cells as Cell-based Therapy | Fathi E, Montazersaheb S, Vandghanooni S, Farahzadi R, Vietor I | Current Molecular Medicine | 2022 |
| ۲۹ | Mesenchymal Stem Cells as a Cell-Based Therapeutic Strategy Targeting the Telomerase Activity of KG1 Acute Myeloid Leukemia Cell | Fathi E- Farahzadi R | Acta Medica Iranica | 2022 |
| ۳۰ | Silver nanoparticles induce the cardiomyogenic differentiation of bone marrow derived mesenchymal stem cells via telomere length extension | Adibkia K-Ehsani A- Jodaei A- Fathi E- Farahzadi R- Barzegar-Jalali M | Beilstein Journal of Nanotechnology | 2021/08/02 |
| ۳۱ | Cytokines and signaling pathways involved in differentiation potential of hematopoietic stem cells towards natural killer cells | Montazersaheb S- Fathi E- Farahzadi R | Tissue and Cell | 2021/06/01 |
| ۳۲ | Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics | Fathi E- Farahzadi R- Montazersaheb S- Bagheri Y | Current Gene Therapy | 2021/02/01 |
| ۳۳ | Mesenchymal stem cells cause telomere length reduction of molt-4 cells via caspase- 3, BAD and P53 apoptotic pathway. | Heidari HR- Fathi E- Montazersaheb S- Mamandi A- Farahzadi R- Zalavi S- Charoudeh HN | International Journal of Molecular and Cellular Medicine | 2021 |
| ۳۴ | L-carnitine in a certain concentration increases expression of cell surface marker CD34 and apoptosis in the rat bone marrow CD34+ hematopoietic stem cells | Fathi E- Pashutan MK- Farahzadi R- Charoudeh HN | Iranian Journal of Veterinary Research | 2021 |
| ۳۵ | Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts | Fathi E Sanaat Z- Farahzadi R | Blood research | 2019/09/01 |
| ۳۶ | Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation | Fathi E- Farahzadi R- Valipour B- Sanaat Z | PloS one | 2019/04/22 |
| ۳۷ | Immunophenotypic characterization, multi-lineage differentiation and aging of zebrafish heart and liver tissue-derived mesenchymal stemcells as a novel approach in stem cell-based therapy | Fathi E- Farahzadi R- Sheikhzadeh N | Tissue and Cell | 2019/04/01 |
| ۳۸ | Telomere shortening as a hallmark of stem cell senescence | Fathi E- Charoudeh HN- Sanaat Z- Farahzadi R | Stem cell investigation | 2019 |
| ۳۹ | Stem cell-based regenerative medicine | Rajabzadeh N- Fathi E*- Farahzadi R | Stem cell investigation | 2019 |
| ۴۰ | Anti-aging protective effect of Lcarnitine as clinical agent in regenerative medicine through increasing telomerase activity and change in the hTERT promoter CpG island methylation status of adipose tissuederived mesenchymal stem cells | Farahzadi R- Fathi E- Mesbah-Namin SA- Zarghami N | Tissue and Cell | 2018/10/01 |